Literature DB >> 7695980

A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities.

J M Klaase1, B B Kroon, A M Eggermont, A N van Geel, H Schraffordt Koops, J Oldhoff, D Liénard, F J Lejeune, R Berkel, H R Franklin.   

Abstract

The aim of this study was to investigate the role of mild hyperthermia (39-40 degrees C) in isolated cytostatic perfusion for patients with recurrent melanoma of the extremities. A total of 218 patients treated with mild hyperthermic perfusion was compared to 166 patients perfused under controlled normothermic conditions (37-38 degrees C). Only patients whose lesions had been excised before or at the moment of perfusion were eligible for this study. A variety of prognostic factors was controlled for in a Cox proportional hazards analysis. The application of mild hyperthermia did not influence limb recurrence-free interval nor survival (corrected P values 0.46 and 0.18, respectively). In this retrospective comparative study, no benefit for mild hyperthermia in regional isolated perfusion could be identified.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695980     DOI: 10.1016/0959-8049(94)00372-c

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Initial experiences with isolated limb perfusion for unresectable melanoma of the limb.

Authors:  L Romics; E A Dy; J C Coffey; D Herlihy; F Aftab; M Z Chaudhry; K Fogarty; J A O'Donnell; H P Redmond
Journal:  Ir J Med Sci       Date:  2011-02-03       Impact factor: 1.568

Review 2.  Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Authors:  A M Eggermont; T L ten Hagen
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

3.  Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).

Authors:  Minhyung Kim; Asher B Blum; Michelle L Haslinger; Michael J Donahue; Daniel T Fisher; Joseph J Skitzki; Il Young Park
Journal:  Surg Today       Date:  2014-07-08       Impact factor: 2.549

4.  Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.

Authors:  Minhyung Kim; Nickolay Neznanov; Chandler D Wilfong; Daria I Fleyshman; Andrei A Purmal; Gary Haderski; Patricia Stanhope-Baker; Catherine A Burkhart; Katerina V Gurova; Andrei V Gudkov; Joseph J Skitzki
Journal:  Cancer Res       Date:  2016-09-28       Impact factor: 12.701

5.  Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

Authors:  P J Kuppen; L E Jonges; C J van de Velde; A L Vahrmeijer; R A Tollenaar; I H Borel Rinkes; A M Eggermont
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.